药闻医讯 | 关于公开征求《罕见病用化学药物药学研究指导原则(征求意见稿)》意见的通知

百诚医药
Aug 18

每周新鲜药闻,百诚与您共同关注!【药闻医讯一周速览】关于公开征求《罕见病用化学药物药学研究指导原则(征求意见稿)》意见的通知;3.25亿美元!授权一款口服抗生素;赛诺菲的授权项目,临床II期成功……政策简报关于公开征求《罕见病用化学药物药学研究指导原则(征求意见稿)》意见的通知罕见病具有发病率/患病率低的重要特征,由于中国人口基数庞大,罕见病患者的绝对数量并不少,存在未被满足的临床需求,是重要的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10